Back
CERo Therapeutics Holdings, Inc. 10K Form
Sell
17
CERO
CERo Therapeutics Holdings, Inc.
Last Price:
$0.09
Seasonality Move:
-39.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CERO News And Ratings
See the #1 stock for the next 7 days that we like better than CERO
CERO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-8.85 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -66.73330 |
|---|---|
| Net Income (TTM): | $-14.7M |
| Gross Margin: | $-1.2M |
| Return on Equity: | 0% |
| Return on Assets: | -214.21% |
CERo Therapeutics Holdings, Inc. Earnings Forecast
Key CERo Therapeutics Holdings, Inc. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 1 years.
CERo Therapeutics Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CERO |
| Website: | cero.bio |
Debt
| Debt-to-Equity Ratio: | -0.2 |
|---|---|
| Current Ratio: | 0.3 |
| Quick Ratio: | 0.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CERO Technical Analysis vs Fundamental Analysis
Sell
17
CERo Therapeutics Holdings, Inc. (CERO)
is a Sell
Is CERo Therapeutics Holdings, Inc. a Buy or a Sell?
-
CERo Therapeutics Holdings, Inc. stock is rated a SellThe current CERo Therapeutics Holdings, Inc. [CERO] share price is $0.09. The Score for CERO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.